ACR适宜性标准®:I期乳腺癌的初始检查及无症状女性局部复发与远处转移的监测
美国放射学会适宜性标准指出,对无症状I期乳腺癌患者,每年乳腺X线摄影是唯一应进行的影像检查以检测局部复发;无证据显示强化影像监测改善生存,生活质量也与强化监测相似;对新诊断I期无症状患者,几乎无理由通过影像检测或排除转移。
要点
- 无症状I期乳腺癌患者,每年乳腺X线摄影是唯一应做的影像检查以检测局部复发。
- 强化影像与实验室监测相比仅按症状或临床检查异常时检查,无生存差异。
- 对新诊断I期无症状女性,几乎无理由通过影像检测或排除转移。
核心结论
- 对无症状I期乳腺癌患者,每年乳腺X线摄影是唯一应进行的影像检查以检测局部复发;无证据支持强化影像监测改善生存或生活质量;对新诊断I期无症状女性,几乎无理由通过影像检测或排除转移。
研究设计与样本
- 美国放射学会适宜性标准,基于证据的指南,由多学科专家小组每年审查;制定与修订包括对同行评议期刊当前医学文献的广泛分析,并应用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像与治疗操作适宜性进行评级;证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。
诊断标准与关键数值
- 美国临床肿瘤学会和国家综合癌症网络指南指出,每年乳腺X线摄影是唯一应进行的影像检查,用于检测无症状患者的局限性乳腺复发。
- 患者有局部区域症状(如可触及异常)时,可能需要更多影像检查。
- 具有增加其终生乳腺癌风险的其他危险因素的女性,可能需要乳腺MRI评估。
临床应用与阅片要点
- 无症状I期乳腺癌患者常规监测中,每年乳腺X线摄影是唯一应进行的影像检查以检测局部复发。
- 患者出现局部区域症状(如可触及异常)时,可能需要更多影像检查。
- 具有增加终生乳腺癌风险的其他危险因素的女性,可能需要乳腺MRI评估。
- 对新诊断I期无症状女性,几乎无理由通过影像检测或排除转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Women and health care professionals generally prefer intensive follow-up after a diagnosis of breast cancer. However, there are no survival differences between women who obtain intensive surveillance with imaging and laboratory studies compared with women who only undergo testing because of the development of symptoms or findings on clinical examinations. American Society of Clinical Oncology and National Comprehensive Cancer Network guidelines state that annual mammography is the only imaging examination that should be performed to detect a localized breast recurrence in asymptomatic patients; more imaging may be needed if the patient has locoregional symptoms (eg, palpable abnormality). Women with other risk factors that increase their lifetime risk for breast cancer may warrant evaluation with breast MRI. Furthermore, the quality of life is similar for women who undergo intensive surveillance compared with those who do not. There is little justification for imaging to detect or rule out metastasis in asymptomatic women with newly diagnosed stage I breast cancer. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
引用
- Moy L, Bailey L, D'Orsi C, et al. ACR Appropriateness Criteria® Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women. J Am Coll Radiol. 2017. PMID: 28473085. doi:10.1016/j.jacr.2017.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。